- Home
- ATRO vs VCYT Comparison
ATRO vs VCYT Comparison
Compare ATRO & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ATRO | VCYT |
|---|---|---|
| Founded | 1968 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Military/Government/Technical | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 2.9B |
| IPO Year | N/A | 2013 |
Fundamental Metrics
Financial Performance| Metric | ATRO | VCYT |
|---|---|---|
| Price | $54.38 | $42.93 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 8 |
| Target Price | ★ $61.50 | $45.38 |
| AVG Volume (30 Days) | 593.1K | ★ 1.0M |
| Earning Date | 11-04-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.38 |
| Revenue | ★ $830,601,000.00 | $495,141,000.00 |
| Revenue This Year | $9.26 | $16.02 |
| Revenue Next Year | $11.51 | $10.74 |
| P/E Ratio | ★ N/A | $112.61 |
| Revenue Growth | 6.19 | ★ 16.41 |
| 52 Week Low | $15.41 | $22.61 |
| 52 Week High | $55.65 | $50.71 |
Technical Indicators
Market Signals| Indicator | ATRO | VCYT |
|---|---|---|
| Relative Strength Index (RSI) | 60.87 | 50.52 |
| Support Level | $49.68 | $45.68 |
| Resistance Level | $53.78 | $45.17 |
| Average True Range (ATR) | 2.46 | 1.95 |
| MACD | 0.12 | -0.70 |
| Stochastic Oscillator | 84.39 | 16.81 |
Price Performance
Historical ComparisonAbout ATRO Astronics Corporation
Astronics Corp supplies products to the aerospace, defense, and electronics industries. The company has two reportable segments namely Aerospace and Test Systems. The aerospace segment serves three primary markets: military, commercial transport, and General Aviation. The Test Systems segment serves the aerospace, defense, and semiconductor markets. The company generates a majority of its revenue from the Aerospace segment. Geographically, it generates a majority of its revenue from the United States.
About VCYT Veracyte Inc.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.